Mastek Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/yqys8l36w850uxg0uuop9hnh.pdf

Key Takeaways


Demand Environment & Order Book

Umang Nahata: "As a company, we have a very unique position with our enterprise application transformation business, our strong data practice as well as a phenomenal engineering practice, which makes us uniquely positioned to become a transformation company, starting these transformations from back office and then taking them forward into the entire business."

Vertical & Geographic Performance

Vertical / GeographyTrendCommentary
U.K. Healthcare▼ Temporary dip, ▲ expectedNHS England timing gap: old project closed, new data modernization and data platform build starting; ramp back to prior levels expected from Q2 into H2.
U.S. Healthcare & Life Sciences▬ Turnaround buildingA key focus area; turnaround not firm for Q2 but management is "quite sure" for H2.
Middle East Healthcare▬ Positive order book, uncertain rampHealthy order book closure in Q1 including a large deal; ramp-up depends on client readiness for transformation execution amid geopolitical instability.
U.K. Financial Services▲ GrowingGood wins in Q4 now moving into execution, with net-new opportunities being pursued.
North America▲ Order book strengthThird consecutive strong quarter; the $25 million AI transformation deal in Salesforce Agentforce is one of the largest in recent quarters; ramp expected by H2FY27.
Middle East (overall)▼ Severe headwindsWest Asia crisis creating instability and unpredictability; some new order book signed later in the quarter but predictability remains uncertain; bench costs and delayed collections impacted EBITDA.
Umang Nahata: "The Middle East business, on the other hand, continues to face some severe headwinds. As we all know, the West Asia crisis is creating a lot of unstability as well as unpredictability in the market."

Margins & Profitability

Umang Nahata: "As we start reaching close to $28 million to $30 million a quarter run rate is where we believe the North America business will start delivering healthy margins of somewhere around mid-teens."

AI Strategy & Internal Transformation

Umang Nahata: "This journey of transforming Mastek from an engineering powerhouse to a transformation powerhouse is what we are really all in for."

Leadership & Organization


Tax Matter


Guidance & Commitments

CommitmentSpecificsTimeline
U.K. Healthcare revenue rampReturn to prior levels and grow from thereQ2 into H2 FY27
Top 5 client performanceReturn to usual performance after NHS timing gapQ2 and beyond
North America deal ramp$25 million, 5-year AI transformation deal begins contributingH2 FY27
North America margin targetMid-teens margins at $28M-$30M quarterly run rateWhen run rate achieved
North America growth inflectionRegion turns into a growth engineH2 FY27
U.S. Healthcare & Life Sciences turnaroundRecovery in the verticalH2 FY27
Middle East collections reversalOnetime EBITDA impact reversesDuring FY27
ESOP grant impact$400,000-$500,000 per quarterStarting Q2 FY27
Increments impact on marginWage increases hit Q2 marginQ2 FY27
AI customer maturity coverageAll customers rated on internal AI maturity modelNext 90-180 days
FY27 full-year performanceBetter than FY26FY27

Key Metrics

MetricQ1 FY27
Revenue$104.8 million, up 1.2% QoQ
Revenue (INR)₹985 crore, up 5% QoQ and 7.7% YoY
Constant currency revenue growth1.8% QoQ
Operating EBITDA margin15.4%
PAT₹105.9 crore, 10.6% of total income
Basic EPS₹34.2, up 14.8% YoY
Diluted EPS₹33.9, up 15% YoY
12-month order backlog$310 million, up 3.2% QoQ and 13.3% YoY in USD terms, 25% YoY in INR terms
North America total backlog growth29.8% QoQ and 23.5% YoY
Data, automation and AI business growth9.8% QoQ
Public sector business growth7.9% QoQ
U.K. business constant currency growth3% QoQ
North America business constant currency growth2% QoQ, 6% in INR
DSO75 days, up 2 days QoQ
Operating cash flow₹27 crore positive
Net cash and investment position improvement₹200 crore over last 2 quarters
Utilization (excluding trainees)Down 2% QoQ
Closing headcount4,897, net addition of 167
LTM attrition16.4%, down from 17.4%
New customers added13
Subcontractor cost18.5% of revenue, in line with Q4
AI-led opportunities closed40-plus
North America large deal win$25 million AI transformation deal, 5-year term
U.K. EBIT~20%
Variable pay paid₹107 crore
Income tax assessment addition (FY23)₹91 crore transfer pricing, ₹32.5 crore domestic tax; tax impact ~₹31 crore
ESOP impact estimate$400,000 to $500,000 per quarter from Q2